Adrenocortical carcinoma
Showing 1 - 25 of 7,763
The Adverse Event of Mitotane Therapy in Adrenocortical
Not yet recruiting
- Adrenocortical Carcinoma
- (no location specified)
Apr 21, 2023
Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)
Recruiting
- Adrenocortical Carcinoma
- 68Ga-R8760 injection at pre-defined dose levels
- 68GA-R8760 injection
-
Ann Arbor, MichiganUniversity of Michigan Nuclear Medicine
Aug 11, 2023
Adrenocortical Carcinoma, ACC, Metastatic Adrenocortical Carcinoma Trial in United States (Ablative Radiotherapy, Pembrolizumab)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- Ablative Radiotherapy
- Pembrolizumab
-
Basking Ridge, New Jersey
- +6 more
Sep 27, 2023
Adrenal Vein Sampling asTool to Identify Biomarkers That Aid
Recruiting
- Adrenocortical Carcinoma
- Blood sampling.
-
Rotterdam, NetherlandsErasmus MC
Dec 14, 2022
Adrenocortical Carcinoma Trial in Brescia (Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG,
Recruiting
- Adrenocortical Carcinoma
- Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
- Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
-
Brescia, ItalyAlfredo Berruti
Jun 12, 2023
Adrenocortical Carcinoma Trial (Pembrolizumab 25 MG/ML [Keytruda])
Not yet recruiting
- Adrenocortical Carcinoma
- Pembrolizumab 25 MG/ML [Keytruda]
- (no location specified)
Sep 29, 2022
Neuroendocrine Neoplasms Including Adrenocortical Carcinoma
Recruiting
- Neuroendocrine Tumors
- Carcinoma, Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Adrenocortical Carcinoma Trial (Camrelizumab)
Recruiting
- Adrenocortical Carcinoma
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Dec 16, 2022
Adrenocortical Carcinoma Trial in Houston (Mitotane, Pembrolizumab)
Not yet recruiting
- Adrenocortical Carcinoma
-
Houston, TexasM D Anderson Cancer Center
Nov 22, 2022
Children and Adults With Adrenocortical Cancer (ACC)
Terminated
- Adrenocortical Carcinoma
- Adrenocortical Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC
Active, not recruiting
- Metastatic Carcinoma in the Adrenal Cortex
- +3 more
- Cabozantinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Survival Analysis in Children and Adults Adrenocortical Cancer
Active, not recruiting
- Adrenocortical Carcinoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jan 20, 2023
Lymph Node Dissection in Surgical Management of Adrenal Cortical
Recruiting
- Adrenocortical Carcinoma
- Adrenalectomy with or without lymphadenectomy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 28, 2023
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Neuroendocrine Carcinomas
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Adrenocortical Carcinoma, Peritoneal Carcinomatosis Trial in New York (Cisplatin, Sodium thiosulfate, Cytoreductive surgery)
Recruiting
- Adrenocortical Carcinoma
- Peritoneal Carcinomatosis
- Cisplatin
- +2 more
-
New York, New YorkColumbia University Medical Center
Mar 17, 2022
Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)
Recruiting
- Adrenocortical Carcinoma
-
Stanford, California
- +5 more
Jun 27, 2022
Serum Free Proteins in Patients With Adrenocortical Carcinoma
Active, not recruiting
- Adrenocortical Carcinoma
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Apr 19, 2022
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8
Not yet recruiting
- Locally Advanced Adrenal Cortical Carcinoma
- +4 more
- Atezolizumab
- +5 more
-
Atlanta, Georgia
- +1 more
Aug 17, 2023
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)
Recruiting
- Adrenocortical Carcinoma
- +2 more
- EO2401
-
Houston, Texas
- +9 more
Dec 7, 2021
ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial
Recruiting
- ENSAT Stage I Adrenal Cortex Carcinoma
- +2 more
- Cisplatin
- +3 more
-
Ann Arbor, Michigan
- +3 more
Dec 13, 2022
Adrenocortical Carcinoma Trial (Pembrolizumab / Lenvatinib)
Not yet recruiting
- Adrenocortical Carcinoma
- Pembrolizumab / Lenvatinib
- (no location specified)
Nov 15, 2021
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +4 more
-
Uppsala, SwedenUppsala University Hospital
Apr 29, 2022